Stem cell therapy to prevent lung damage in premature babies
Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests whether giving stem cells to very premature babies can help prevent bronchopulmonary dysplasia, a lung condition that often affects babies born before 28 weeks. The stem cells are given through an IV, and the study compares them to a placebo to see if they improve lung health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born before 28 weeks of pregnancy.
- Your baby must be between 4 and 14 days old.
- Your baby must be on a breathing machine and need extra oxygen at 30% or more for at least 12 hours in a 24-hour period.
- Your baby cannot have certain serious birth defects or genetic conditions.
- Your baby cannot be in shock, have a severe infection, a collapsed lung with a chest tube, or active bleeding in the lungs.
- Your baby's doctors must not be planning to remove the breathing tube within the next 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called dexamethasone (a steroid) can help prevent a serious lung problem in very premature babies. It is for babies who still need a breathing machine after two weeks of life.
This Phase 1 trial tests whether giving stem cells into a breathing tube is safe and may help prevent bronchopulmonary dysplasia (BPD), a serious lung condition in very premature infants. It focuses on babies soon after birth who already need breathing support and are at risk.
This trial tests if stem cells can help premature babies with severe lung disease (bronchopulmonary dysplasia). It is for very small, early-born babies who still need a breathing machine between 5 and 14 days after birth.
This trial tests whether umbilical cord stem cells can help premature babies with severe bronchopulmonary dysplasia (a chronic lung disease) who still need a breathing tube after standard hormone treatment. The goal is to see if it is safe and improves their lung condition.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
This trial tests an experimental stem cell medicine (called PNEUMOSTEM) given to very premature babies who have early signs of high blood pressure in the lungs (pulmonary hypertension). The goal is to see if it can improve breathing and overall outcomes for these fragile infants.
Hear when a new Bronchopulmonary Dysplasia (BPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.